THE DEAL, AT A GLANCE
From the announcementAbsci
01Who is involvedBacked by Viking Global, Casdin CapitalFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedAbsci raised $200M Series EFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersAbsci is using its $200M Series E to move AI-designed antibody drug candidates toward clinical trials, positioning generative drug design and cell line engineering as a…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Absci · Financing Record
Explore source-linked visual explanations for Absci. Unsupported claims are withheld while source review continues.
Record 463 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →